Full Text View
Tabular View
No Study Results Posted
Related Studies
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With DME (MIVI-II)
This study is ongoing, but not recruiting participants.
Study NCT00412451   Information provided by ThromboGenics
First Received: December 14, 2006   Last Updated: April 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Macular Edema
Additional conditions recognized in this trial
Edema
Macular Edema
More general conditions related to this trial
Eye Diseases
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Interventions listed in this trial
Microplasmin
Sham injection
Sponsors listed in this trial
ThromboGenics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services